Back To: Home : Featured Technology : Stem Cell

CLICK HERE FOR WHAT'S NEW IN:
 

Cardiomyocytes for predictive toxicity testing
January 2012
SHARING OPTIONS:

GE Healthcare  
 
Cytiva Cardiomyocytes from GE Healthcare are derived from U.S. National Institutes of Health-approved human embryonic stem cells and provide a biologically relevant alternative to current cell models and primary cells for predictive toxicity testing.  

GE Healthcare

www.gelifesciences.com/drugdiscoverysuite
Visit us at SLAS 2012 booth #1232
  
 

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.